Neurofilament Light Chain Levels, Skeletal Muscle Loss, and Nutritional Decline: Key Prognostic Factors in Amyotrophic Lateral Sclerosis
- PMID: 40183173
- PMCID: PMC12138481
- DOI: 10.1002/mus.28407
Neurofilament Light Chain Levels, Skeletal Muscle Loss, and Nutritional Decline: Key Prognostic Factors in Amyotrophic Lateral Sclerosis
Abstract
Introduction/aims: Hypermetabolism and weight loss are established negative prognostic factors in amyotrophic lateral sclerosis (ALS). However, the role of individualized body composition parameters in predicting ALS progression has been underexplored. This study aimed to investigate the correlation between nutritional parameters, neurofilament light chain (NfL) levels, and disease progression in ALS patients.
Methods: The Global Leadership Initiative on Malnutrition criteria were used to define malnutrition in this study. Nutritional status was assessed using body mass index and bioelectrical impedance analysis. The rate of disease progression was defined by the change in the Revised ALS Functional Rating Scale score (ΔFRS). NfL was quantified using single molecule array technology. Spearman's analyses were used to assess correlations.
Results: Sixty of 110 ALS patients were classified as malnourished. There was a strong positive correlation between NfL and ΔFRS (r = 0.71), and a moderate negative correlation with disease duration (r = -0.55). The correlations between NfL and body composition parameters were statistically significant, although weak. NfL levels were significantly higher in fast progressors (p < 0.0001 compared to slow progressors) and in malnourished patients (p = 0.0001). Of the 34 fast progressor patients, 28 (82%) exhibited some degree of malnutrition.
Discussion: Our findings indicate that poor nutritional status, particularly reduced skeletal muscle mass-both independently and in combination with fat mass loss-is associated with elevated NfL levels and faster ALS progression. NfL, combined with nutritional parameters, could serve as a valuable biomarker for disease severity. Further research is warranted to clarify the role of skeletal muscle abnormalities in ALS progression.
Keywords: amyotrophic lateral sclerosis; malnutrition; neurofilament light chain; rehabilitation; sarcopenia.
© 2025 The Author(s). Muscle & Nerve published by Wiley Periodicals LLC.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures


References
-
- Muscaritoli M., Kushta I., Molfino A., Inghilleri M., Sabatelli M., and Rossi Fanelli F., “Nutritional and Metabolic Support in Patients With Amyotrophic Lateral Sclerosis,” Nutrition 28, no. 10 (2012): 959–966. - PubMed
-
- Essat M., Coates E., Clowes M., et al., “Understanding the Current Nutritional Management for People With Amyotrophic Lateral Sclerosis – A Mapping Review,” Clinical Nutrition ESPEN 49 (2022): 328–340. - PubMed
-
- Azzolino D., Piras R., Zulueta A., Lucchi T., and Lunetta C., “Amyotrophic Lateral Sclerosis as a Disease Model of Sarcopenia,” Age and Ageing 53, no. 9 (2024): afae209. - PubMed
-
- Cattaneo M., Jesus P., Lizio A., et al., “The Hypometabolic State: A Good Predictor of a Better Prognosis in Amyotrophic Lateral Sclerosis,” Journal of Neurology, Neurosurgery, and Psychiatry 93, no. 1 (2022): 41–47. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous